Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CellCept vs Avonex and Combination in RRMS
NCT00324506Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- May 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolate mofetil in multiple sclerosis (MS), sponsored by UT Southwestern Medical Center. Started May 2006; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00324506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324506.